SEC Form 4 · accession 0001179110-16-019783
AbbVie Inc. · ABBV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy J. Richmond
Officer — SVP, Human Resources
Period of report
Feb 18, 2016
Accepted (ET)
Feb 22, 2016 · 5:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001551152
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1 | $54.86 | Feb 18, 2016 | A | 42,370 | A | Feb 18, 2017 | Feb 17, 2026 | Common stock | 42,370 | 42,370 | D |
Explanation of responses
- F1Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.The option becomes exerciseable in annual increments of 14,124 on 02/18/2017, 14,123 on 02/18/2018, and 14,123 on 02/1/8/2019.